AnnJi Pharmaceutical Company Announces Positive Phase 1/2a Results for AJ201 in Spinal and Bulbar Muscular Atrophy (SBMA) Patients ...Middle East

TAIPEI, May 21, 2025 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd., a clinical-stage Taiwanese biotechnology company focused on addressing unmet medical needs in dermatology, neurology, and rare diseases, today announced positive results from its Phase 1/2a randomized, double-blind,...

Hence then, the article about annji pharmaceutical company announces positive phase 1 2a results for aj201 in spinal and bulbar muscular atrophy sbma patients was published today ( Thursday 22/05/2025 - 04:20 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AnnJi Pharmaceutical Company Announces Positive Phase 1/2a Results for AJ201 in Spinal and Bulbar Muscular Atrophy (SBMA) Patients )

Also on site :

• Disgraced former Centinela Valley schools Superintendent Jose Fernandez dies
• Tyler Perry Sued for Sexual Assault By New Accuser, an Actor in a ‘Madea’ Movie
• New law revives dormant plans for solar plant near Mojave National Preserve